Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019-2020 Season in Philadelphia, Pennsylvania., PMID:40452165
Acute Respiratory and Influenza Viruses Circulating in Kazakhstan During 2018-2024., PMID:40430813
Immune responses after one versus two Influenza A/B vaccinations in patients with multiple myeloma., PMID:40372494
Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years: A Randomized Clinical Trial., PMID:40332892
Seroprevalence of anti-influenza antibodies in humans and characterization of seasonal influenza viruses isolated in Russia during the 2023-2024 flu season., PMID:40307541
Sulfatide Binds to Influenza B Virus and Enhances Viral Replication., PMID:40284974
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination., PMID:40265888
Influenza A hemagglutinin virus-like particles confer protection against influenza B virus infection., PMID:40230200
Intranasal administration of a panreactive influenza antibody reveals Fc-independent mode of protection., PMID:40199998
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses., PMID:40193611
An mRNA-based seasonal influenza vaccine in adults: Results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titers., PMID:40174609
Neuraminidase-specific antibodies drive differential cross-protection between contemporary FLUBV lineages., PMID:40153499
Drug-Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice., PMID:40097766
Selection and identification of an ssDNA aptamer against influenza B virus hemagglutinin protein., PMID:40050943
A novel tetravalent influenza vaccine based on one chimpanzee adenoviral vector., PMID:40023902
Adenoviral-Vectored Multivalent Vaccine Provides Durable Protection Against Influenza B Viruses from Victoria-like and Yamagata-like Lineages., PMID:40004004
Immunogenicity and safety of 1 versus 2 doses of quadrivalent-inactivated influenza vaccine in children aged 3-8 years with or without previous influenza vaccination histories., PMID:39993940
Development and evaluation of mosaic VLPs vaccine for enhanced broad-Spectrum immunity against influenza B virus lineages in mice., PMID:39970593
A single mutation at position 214 of influenza B hemagglutinin enhances cross-neutralization., PMID:39960410
Integrative Mapping of Pre-existing Immune Landscapes for Vaccine Response Prediction., PMID:39896552
Correlation Between Inflammatory Markers and Pathogenic Bacteria in Children's Winter Respiratory Infections in Xinjiang., PMID:39867248
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients., PMID:39794319
Delay of innate immune responses following influenza B virus infection affects the development of a robust antibody response in ferrets., PMID:39772665
Simultaneous Detection of Five Infectious Diseases in a Single Strip: Oligo dT-Utilized Lateral Flow Immunoassay., PMID:39745343
Molecular epidemiological analysis of Influenza viruses in Influenza-like illness cases: a retrospective study in Chongqing Hi-Tech Zone, China (2021-2024)., PMID:39741357
Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges., PMID:39648102
Seasonal influenza vaccines: Variability of immune responses to B lineage viruses., PMID:39552079
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach., PMID:39551795
mRNA encoding antibodies against hemagglutinin and nucleoprotein prevents influenza virus infection in vitro., PMID:39504717
Hemagglutination-Inhibition Antibodies and Protection against Influenza Elicited by Inactivated and Live Attenuated Vaccines in Children., PMID:39504434
The self-assembled nanoparticle-based multi-epitope influenza mRNA vaccine elicits protective immunity against H1N1 and B influenza viruses in mice., PMID:39445022
mRNA-based influenza vaccine expands breadth of B cell response in humans., PMID:39416092
Smoking and serological response to influenza vaccine., PMID:39400298
Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel., PMID:39395753
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA., PMID:39379405
Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID-19 epidemic in Wuhan, China., PMID:39370830
Triton X-100-treated virus-based ELLA demonstrates discordant antigenic evolution of influenza B virus hemagglutinin and neuraminidase., PMID:39360825
Establishment of a Raman nanosphere based immunochromatographic system for the combined detection of influenza A and B viruses' antigens on a single T-line., PMID:39321818
A Transgenic Mouse With a Humanized B-Cell Repertoire Mounts an Antibody Response to Influenza Infection and Vaccination., PMID:39317662
Epidemiological trends in respiratory pathogens infections among children post-COVID-19: A cross-sectional study., PMID:39263168
Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction., PMID:39257041
Safety and immunogenicity of mRNA-based seasonal influenza vaccines formulated to include multiple A/H3N2 strains with or without the B/Yamagata strain in US adults aged 50-75 years: a phase 1/2, open-label, randomised trial., PMID:39245055
Antigenic analysis of the influenza B virus hemagglutinin protein., PMID:39233140
Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients., PMID:39219510
Evaluation of a qualified MDCK cell line for virus isolation to develop cell-based influenza vaccine viruses with appropriate antigenicity., PMID:39213922
Analysis of the epidemic characteristics of common respiratory pathogens infection in children in a 3A special hospital., PMID:39210260
Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses., PMID:39171925
A broad-spectrum multiepitope vaccine against seasonal influenza A and B viruses in mice., PMID:39111250
Disulfide-stabilized trimeric hemagglutinin ectodomains provide enhanced heterologous influenza protection., PMID:39101691
Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial., PMID:39099085
For research use only. Not for human or drug use.
